Takeda: Diabetes Mellitus trials

The registry lists 109 Diabetes Mellitus studies with Takeda as lead sponsor. 0 are open to participants now and 70 have results posted.

Phase 1 3Phase 2 21Phase 3 58Phase 4 14No phase 20(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Efficacy of SYR-472 in Subjects With Type 2 Diabetes MellitusCompletedNCT00653185Phase 2
• Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart FailureTerminatedNCT00521820Phase 3
• Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac DiseaseCompletedNCT00521742Phase 3
• Safety Study of Pioglitazone Compared To Glyburide on Liver FunctionCompletedNCT00494312Phase 4
• Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone.CompletedNCT00449553
• Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes MellitusTerminatedNCT00376181Phase 3
• Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and DyslipidemiaCompletedNCT00331487Phase 3
• Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease.CompletedNCT00225264Phase 3
• Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 DiabetesCompletedNCT00174993Phase 3